Mangalore Refinery And Petrochemicals Ltd
Mangalore Refinery & Petrochemicals Limited (MRPL) was set up as a joint venture (JV) between the AV Birla Group and Hindustan Petroleum Corporation Limited (HPCL). It is now a subsidiary of Oil & Natural Gas Corporation(ONGC). The company is mainly engaged in the business of refining crude oil, petrochemical business, trading of aviation fuels and distribution of petroleum products through retail outlets and transport terminals. [1][2]
- Market Cap ₹ 25,222 Cr.
- Current Price ₹ 144
- High / Low ₹ 254 / 98.9
- Stock P/E 449
- Book Value ₹ 74.0
- Dividend Yield 2.08 %
- ROCE 4.33 %
- ROE 0.43 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Energy Oil, Gas & Consumable Fuels Petroleum Products Refineries & Marketing
Part of BSE 500 BSE PSU Nifty 500 BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
71,552 | 57,398 | 39,730 | 43,767 | 49,055 | 63,446 | 50,230 | 31,959 | 69,758 | 109,026 | 90,407 | 94,682 | |
70,538 | 59,565 | 38,021 | 38,775 | 44,526 | 60,816 | 53,368 | 31,252 | 64,814 | 102,498 | 82,562 | 92,389 | |
Operating Profit | 1,015 | -2,167 | 1,709 | 4,992 | 4,529 | 2,630 | -3,137 | 708 | 4,944 | 6,528 | 7,845 | 2,293 |
OPM % | 1% | -4% | 4% | 11% | 9% | 4% | -6% | 2% | 7% | 6% | 9% | 2% |
432 | 841 | 674 | 2,015 | 223 | 130 | 70 | 90 | 67 | 213 | 55 | 181 | |
Interest | 323 | 448 | 1,083 | 969 | 915 | 1,062 | 1,251 | 558 | 1,212 | 1,298 | 1,119 | 1,008 |
Depreciation | 707 | 522 | 1,013 | 984 | 966 | 1,048 | 1,086 | 1,158 | 1,088 | 1,187 | 1,257 | 1,347 |
Profit before tax | 418 | -2,295 | 287 | 5,054 | 2,871 | 651 | -5,404 | -919 | 2,711 | 4,256 | 5,523 | 119 |
Tax % | -45% | -19% | -77% | 35% | 38% | 46% | -25% | -17% | -9% | 38% | 35% | 53% |
606 | -1,853 | 506 | 3,293 | 1,774 | 351 | -4,043 | -765 | 2,958 | 2,655 | 3,597 | 56 | |
EPS in Rs | 3.46 | -10.29 | 4.70 | 19.81 | 11.37 | 1.94 | -19.14 | -4.36 | 16.88 | 15.15 | 20.52 | 0.32 |
Dividend Payout % | 0% | 0% | 0% | 30% | 26% | 52% | 0% | 0% | 0% | 0% | 15% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 14% |
3 Years: | 11% |
TTM: | 5% |
Compounded Profit Growth | |
---|---|
10 Years: | 7% |
5 Years: | 15% |
3 Years: | -73% |
TTM: | -98% |
Stock Price CAGR | |
---|---|
10 Years: | 7% |
5 Years: | 35% |
3 Years: | 6% |
1 Year: | -30% |
Return on Equity | |
---|---|
10 Years: | 12% |
5 Years: | 20% |
3 Years: | 19% |
Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 1,753 | 1,753 | 1,753 | 1,753 | 1,753 | 1,753 | 1,753 | 1,753 | 1,753 | 1,753 | 1,753 | 1,753 |
Reserves | 5,337 | 3,478 | 4,281 | 7,750 | 8,481 | 8,193 | 4,607 | 2,495 | 5,457 | 8,112 | 11,530 | 11,217 |
9,840 | 14,702 | 14,395 | 15,477 | 14,921 | 15,618 | 18,482 | 24,062 | 21,310 | 16,939 | 12,687 | 13,143 | |
22,698 | 21,294 | 23,650 | 7,870 | 6,803 | 7,203 | 5,734 | 6,425 | 11,561 | 8,410 | 9,467 | 8,322 | |
Total Liabilities | 39,628 | 41,226 | 44,080 | 32,849 | 31,958 | 32,766 | 30,576 | 34,735 | 40,081 | 35,214 | 35,437 | 34,435 |
5,995 | 21,641 | 21,747 | 20,618 | 20,217 | 20,002 | 20,431 | 19,596 | 21,384 | 20,396 | 20,410 | 20,104 | |
CWIP | 8,552 | 1,389 | 198 | 220 | 682 | 995 | 1,746 | 2,343 | 170 | 475 | 744 | 720 |
Investments | 0 | 0 | 38 | 42 | 31 | 29 | 29 | 25 | 29 | 46 | 48 | 55 |
25,081 | 18,197 | 22,097 | 11,969 | 11,028 | 11,740 | 8,369 | 12,770 | 18,499 | 14,297 | 14,234 | 13,555 | |
Total Assets | 39,628 | 41,226 | 44,080 | 32,849 | 31,958 | 32,766 | 30,576 | 34,735 | 40,081 | 35,214 | 35,437 | 34,435 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
8,597 | -731 | 1,429 | -1,108 | 3,972 | 1,640 | 289 | -2,818 | 4,496 | 6,364 | 7,045 | 1,878 | |
-919 | -94 | 303 | -265 | -981 | -1,080 | -1,449 | -2,101 | -595 | -673 | -1,518 | -940 | |
1,419 | -2,672 | -1,744 | 265 | -2,796 | -996 | 1,157 | 4,944 | -3,922 | -5,690 | -5,524 | -938 | |
Net Cash Flow | 9,097 | -3,497 | -12 | -1,109 | 194 | -436 | -3 | 24 | -20 | 1 | 3 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 23 | 14 | 19 | 22 | 19 | 14 | 7 | 28 | 23 | 15 | 16 | 14 |
Inventory Days | 44 | 24 | 36 | 44 | 45 | 39 | 30 | 90 | 62 | 25 | 38 | 32 |
Days Payable | 110 | 116 | 223 | 60 | 41 | 29 | 24 | 50 | 55 | 23 | 33 | 24 |
Cash Conversion Cycle | -43 | -78 | -168 | 6 | 23 | 24 | 14 | 67 | 29 | 17 | 21 | 21 |
Working Capital Days | -47 | -94 | -168 | -14 | -16 | -1 | -7 | 49 | 23 | 14 | 16 | 17 |
ROCE % | -10% | 7% | 19% | 15% | 7% | -16% | -1% | 14% | 20% | 26% | 4% |
Documents
Announcements
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Intimation Of Grant Of US Patent.
30 May - MRPL granted US patent for innovative Isobutyl Benzene synthesis process, advancing pharmaceutical production.
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
30 May - MRPL fined ₹13.7 lakh each by NSE and BSE for board non-compliance; now compliant after director appointments.
-
Notice Received From BSE And NSE For Non-Compliance Of Regulation 17(1), 18(1), 19, 20 And 21(2) Of SEBI (LODR) Regulations, 2015 For The Quarter Ended December 31, 2024
30 May - MRPL fined ₹13.71L for board non-compliance; reconstituted board with independent directors by March 28, 2025.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
27 May - Annual Secretarial Compliance Report with noted non-compliances and fines, company pursuing regulatory compliance.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
30 Apr - Transcript of Conference Call held with Analysts and Investors to discuss the Audited Financial Results for the quarter and year ended March 31, 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Apr 2025TranscriptPPTREC
-
May 2024TranscriptPPT
Business Segments
1.Retail: The company entered the Retail fuel service stations business under the brand ‘HiQ’. As of FY24, it has a network of 101 retail outlets across Karnataka and Kerala. [1] [2]
In FY24, the total retail sales volume in the domestic market was 2.6 MMT with a sales value of Rs. ~15,400 Cr vs 1.9 MMT with a sales value of Rs. ~11,000 Cr in FY22. [2] [3]